Heather Bresch, the Mylan CEO under fire for skyrocketing EpiPen costs, believes Americans should redirect their anger toward a "broken" health care system.
Mylan (MYL) was forced to respond to the national outrage over a more than 400% increase in price for the lifesaving allergy treatment by pledging on Thursday to make it more affordable.
EpiPen CEO: Blame the 'broken' system, not me - Aug. 25, 2016
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.